openPR Logo
Press release

Acne Medication Market Analysis Focusing on Top Key Players – Allergan Plc., Nestle S.A. (Galderma S.A.), Johnson & Johnson, Mayne Pharma Group Limited, Mylan N.V., Pfizer Inc.

12-04-2018 12:54 PM CET | Health & Medicine

Press release from: Allied Market Research

Acne Medication Market

Acne Medication Market

Acne Medication Market is projected to reach $10,929 million by 2025, registering a CAGR of 3.9% from 2018 to 2025.

Acne is a long-term skin disease that appears because of clogged hair follicles, dead skin cells, and oil excreted from skin. It is characterized by the presence of considerable number of pimples, whiteheads, blackheads, oily skin, and probable scarring. It generally affects the skin with comparatively high number of sweat glands at upper part of chest, back, and face. Acne medications are drugs that are indicated for the treatment of acne. These include several prescription and over-the-counter medicines such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, oral contraceptives, and others.

The factors that drive the growth of the acne medication market include increase in prevalence of acne vulgaris across the world, unhealthy urban lifestyle, surge in pollution, and rise in focus on skin care products. However, side effects associated with acne medications and reforms, and presence of alternative treatment options such as laser therapies, impede the market growth. Conversely, the development of newer products with lesser side effects and presence of untapped market in the emerging economies are expected to provide lucrative growth opportunities for the market.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4356?utm_source=sy-Openpr

Key players of this market include
• Allergan Plc.
• Nestle S.A. (Galderma S.A.)
• Johnson & Johnson
• Mayne Pharma Group Limited
• Mylan N.V.
• Pfizer Inc.
• GlaxoSmithKline Plc (Stiefel Laboratories Inc.)
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.
• Valeant Pharmaceuticals International Inc.

The retinoids segment accounted for the largest share in 2017, owing to high usage in treatment of acne and lesser side effects as compared to other therapeutics. However, the salicylic acid segment is expected to grow at the high CAGR from 2018 to 2025.

The inflammatory acne segment is the largest acne type segment in the global acne medication market in 2017 and is expected to maintain its lead in the forecast period. On the other hand, non-inflammatory acne segment is anticipated to record the highest CAGR from 2018-2025.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/4356?utm_source=sy-Openpr

By type, the prescription medicine segment dominated the global acne treatment market in terms of revenue in 2017 and the trend is projected to continue throughout the forecast period.

The utilization rate of topical medications for acne treatment is high owing to high availability of these products with high success rate and lesser side effects. However, the oral medication segment is expected to grow at a CAGR of 3.6% during the forecast period.

Key Findings of the Acne Medication Market:
• The antibiotics segment accounted for nearly one-fourth share of the global acne medication market in 2017.
• The over-the-counter medicine segment is expected to grow at a CAGR of 2.9% from 2018 to 2025.
• The non-inflammatory acne segment accounted for around two-fifths share of the global market in 2017.
• Europe accounted for around one-fourth share of the global market in 2017.
• LAMEA is expected to provide lucrative market growth opportunities and grows with the CAGR of 4.5% from 2018 to 2025.

North America was the leading revenue contributor to the global acne medication market in 2017, and is expected to dominate the market during the forecast period. This is attributed to the early approval of acne medication products and high adoption of prescription medicines in this region. However, Asia-Pacific is expected to grow at the highest CAGR of 5.6% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward safe acne medications products.

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/acne-medication-market.html?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acne Medication Market Analysis Focusing on Top Key Players – Allergan Plc., Nestle S.A. (Galderma S.A.), Johnson & Johnson, Mayne Pharma Group Limited, Mylan N.V., Pfizer Inc. here

News-ID: 1416177 • Views:

More Releases from Allied Market Research

PA66 Market Size, Industry Share, Growth, Regional Forecast, 2031
PA66 Market Size, Industry Share, Growth, Regional Forecast, 2031
As per the report published by Allied Market Research, the global PA66 market was pegged at $5.9 billion in 2021, and is expected to reach $9.8 billion by 2031, growing at a CAGR of 5.5% from 2022 to 2031. The report provides an in-depth analysis of top segments, changing market trends, value chain, key investment pockets, competitive scenario, and regional landscape. The report is an essential and helpful source of
Non-Honeycomb Sandwich Panel Core Materials Market Trends, Industry Size and Business Analysis Report 2030
Non-Honeycomb Sandwich Panel Core Materials Market Trends, Industry Size and Bus …
The global non-honeycomb sandwich panel core materials market size valued at $0.7 billion in 2020, and is projected to reach $1.6 billion by 2030, growing at a CAGR of 7.7% from 2021 to 2030. According to a new report published by Allied Market Research titled, "Non-Honeycomb Sandwich Panel Core Materials Market: Global Opportunity Analysis and Industry Forecast, 2021-2030," Asia-Pacific is dominating the non-honeycomb sandwich panel core materials market, and is expected
The Future of Eco-Friendly Commuting : Electric Bike Kits Set to Reach $2,902.4 Million by 2032
The Future of Eco-Friendly Commuting : Electric Bike Kits Set to Reach $2,902.4 …
Allied Market Research published a report, titled, "Electric Bike Kit Market by Usage, (Mountain Bicycle, Road Bicycle, Cargo Bicycle and Others), Battery (Lithium-Ion, Lead Acid, and Others), and Speed, (Up to 25 kmph, 25-45 kmph, and Above 45 kmph): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global electric bike kit industry size generated $1,095.3 million in 2022 and is estimated to reach $2,902.4 million by
Global Passenger Car Accessories Aftermarket Accelerates Towards $248.41 Billion by 2026
Global Passenger Car Accessories Aftermarket Accelerates Towards $248.41 Billion …
As per the report published by Allied Market Research, the global passenger car accessories aftermarket was pegged at $128.97 billion in 2018, and is expected to reach $248.41 billion by 2026, growing at a CAGR of 8.5% from 2019 to 2026. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 - https://www.alliedmarketresearch.com/request-sample/A06108 Stringent government regulations to upgrade the accessories, increase in the trend of vehicle customization, rise in disposable income, and high focus on well-being of drivers have

All 5 Releases


More Releases for Acne

Rising Cases of Acne Boosting Professional Acne Treatment Market Growth
Factor such as the rising cases of acne, surging adoption of acne treatments, growing healthcare spending, increasing disposable income, sedentary lifestyle, strong product pipeline, and mounting number of research programs are expected to propel the professional acne treatment market at a CAGR of 7.6% during 2020–2030. According to P&S Intelligence, the market size is expected to reach $13,124.5 million by 2030 from $6,298.9 million in 2020. Moreover, the market is
Acne Drugs: Global Markets
The global market for acne drugs was valued at REDACTED in 2019. The market is expected to growat a compound annualgrowth rate (CAGR) of REDACTED to reach REDACTED by 2025. Growth of the global market is attributed the increasing numberof cases of acne and skin diseases, unhealthy eating habits and the rising adoption of skin care productsworldwide. To Get Sample Copy of Report Visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=2798596 Increasing prevalence of the acne and
Acne Drugs Market
According to IMARC Group’s latest report, titled “Acne Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”. Looking forward, IMARC Group expects the global acne drugs market to continue its moderate growth during the next five years. Acne drugs are medications used to treat a dermatological infection caused by the inflammation in the hair follicles on the skin. It is generally due to hormonal imbalance, oily skin, accumulation of
Acne Vulgaris Treatment Market
Acne vulgaris is a common skin disease characterized by blackheads, whiteheads, papules, and pustules on the face, neck, back, and chest. It is commonly observed in adolescent population, however, can also affect adults. Depending on its severity, acne may be segmented into mild, moderate or severe. It is caused due to excess oil produced in sebaceous glands under skin, which becomes plugged and inflated. Female patient with polycystic ovarian syndrome
Global Market Study on Acne Treatment Inflammatory Acne Segment Anticipated.
The global acne treatment market is stagnant in terms of incremental innovation as most players are investing in product reformulation instead of new product development. The analysts of Persistence Market Research have come up with a new publication titled “Acne Treatment Market: Global Industry Analysis and Forecast, 2017 – 2025,” and have observed that the North America region is expected to witness significant growth in market revenue due to rising affinity
Acne solution
Understanding acne and the different types of acne people suffer from can help in determining what methods of acne control should be attempted, without risk of worsening the condition, or possibly causing permanent damage to the skin. The medical community has had no luck in pinpointing the exact cause of acne and a single effective method for acne control, but the source of acne has been discovered to be the